Search

Search Constraints

You searched for: Author/Creator Wallenstein, Gene

Search Results

2. Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs. Issue 1 (December 2015)

3. Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies. (25th July 2016)

5. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study. Issue 3 (25th February 2013)

6. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study12. Issue 3 (25th February 2013)

7. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study12. Issue 3 (25th February 2013)

8. Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study. Issue 6 (24th April 2019)

9. Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial. Issue 2 (28th September 2016)